FIELD: veterinary medicine.
SUBSTANCE: invention relates to a veterinary composition that can be used to control iron deficiency and/or anemic conditions in a non-human mammal. The proposed veterinary composition contains an aqueous colloidal solution of beta-iron oxyhydroxide and glucopentonic acid dextran as the only active ingredient and polyvinylpyrrolidone.
EFFECT: use of polyvinylpyrrolidone provides increased antianemic efficacy and improved tissue distribution of the iron complex in non-human mammals.
14 cl
| Title | Year | Author | Number |
|---|---|---|---|
| DOSAGE FORM AND USE OF DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER OR BREAST CANCER | 2012 |
|
RU2602296C2 |
| COMPLEX IRON COMPOUNDS FOR THERAPEUTIC USE | 2018 |
|
RU2812636C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PLASMINOGEN, AND USE THEREOF | 2015 |
|
RU2711989C2 |
| PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC THERAPEUTIC AGENTS AND COMPOSITIONS CONTAINING IT | 2006 |
|
RU2429850C2 |
| TREATING OR PREVENTING ANAEMIA IN PREGNANT NON-HUMAN MAMMALS | 2015 |
|
RU2712211C2 |
| TRIAZINE FORMULATIONS WITH SECOND ACTIVE INGREDIENT AND SURFACTANT (-S) | 2013 |
|
RU2652136C2 |
| TOSYLATE SALT OF TRANS-N-ISOBUTYL-3-FLUORO-3-[3-FLUORO-4-(PYRROLIDIN-1-YLMETHYL)PHENYL]CYCLOBUTANE CARBOXAMIDE | 2008 |
|
RU2451016C2 |
| PHOSPHATE ADSORBENT BASED ON IRON (III) COMPOUNDS AND CARBOHYDRATES | 2007 |
|
RU2447933C2 |
| PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM | 2006 |
|
RU2623206C2 |
| WATER-DISSOLVED INCLUSION COMPLEX OF BENZOTHIOPHENE COMPOUNDS WITH WATER-SOLUBLE CYCLODEXTRIN, METHOD OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2135176C1 |
